date:Oct 19, 2017
researchers looked at other similar molecules to see if they worked instead.
They identified isorhapontigenin as having the potential to be developed into a drug to treat COPD.
Corticosteroids, which are commonly used for reducing inflammation, are not effective in COPD patients, said Lin Haishu from the National University of Singapore.
This compound, isorhapontigenin, uses a biological pathway that is different from corticosteroids to inhibit the release of inflammatory mediators in the bod